Ionis Pharmaceuticals Stock (NASDAQ: IONS) stock price, news, charts, stock research, profile.
|Vol / Avg.742.018K / 1.115M||Mkt Cap6.986B|
|Day Range48.510 - 49.460||52 Wk Range32.690 - 51.890|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-03||Goldman Sachs||Salveen Richter||Maintains||SellSell||Raises||25.00||28.00|
|2023-11-03||Morgan Stanley||Michael Ulz||Maintains||Equal-WeightEqual-Weight||Raises||45.00||48.00|
|2023-10-23||B of A Securities||Jason Gerberry||Upgrades||UnderperformNeutral||Raises||33.00||52.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Ionis Pharmaceuticals (NASDAQ: IONS) through any online brokerage.
The latest price target for Ionis Pharmaceuticals (NASDAQ: IONS) was reported by Needham on Friday, November 17, 2023. The analyst firm set a price target for 60.00 expecting IONS to rise to within 12 months (a possible 23.23% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $48.69 last updated December 8, 2023 at 9:00 PM UTC.
There is no dividend information for Ionis Pharmaceuticals.
Ionis Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 21, 2024.
There is no upcoming split for Ionis Pharmaceuticals.
Ionis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.